Search for: "PAR PHARMACEUTICALS" Results 261 - 280 of 303
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jan 2009, 7:04 am
Today when I compared my initial days with recent times, I feel that Indian Patent Examiners are inching at par with US and European counterparts. [read post]
23 Dec 2008, 7:00 pm
It was withdrawn at Par Pharmaceuticals based on the Board of Directors' commitment to adopt the policy in 2009. [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @ Gowlings) (Hal… [read post]
29 Oct 2008, 12:14 pm
" At least thee companies (Par Pharmaceutical Companies, MBIA and Blockbuster) have committed to providing an advisory vote in 2009; A number of companies where shareholders have approved say on pay have not implemented the practice. [read post]
18 Oct 2008, 8:19 am
In the Hatch-Waxman area, Pozen, Inc. announced Par Pharmaceutical Inc. has filed an application with the Food and Drug Administration [FDA] to make a generic version of Treximet, a migraine treatment Pozen developed with GlaxoSmithKline PLC, and shares of Pozen shed nearly 28 percent of their value on 17 Oct. 08 [read post]
26 Jun 2008, 5:00 pm
  Ingersoll (not a typo, the proposal has been approved by shareholders twice at this company), Motorola, Verizon Communications, Blockbuster, Activision, Clear Channel Communications, and Par Pharmaceutical. [read post]
6 May 2008, 10:20 pm
 Falabella was fined approximately with U$8,000,000 and Almacenes París was fined U$5,000,000. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma USA… [read post]
29 Apr 2008, 7:49 pm
Nevertheless, the '589 patent uses "consisting of" language in its description of the pharmaceutical formulations. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
26 Mar 2008, 9:15 pm
In other words, even when the criminal justice system would normally seek to punish offenders for serious wrongs, it might be par-ticularly difficult to do so when the offender is a wealthy or powerful person or entity. [read post]
11 Mar 2008, 5:15 am
  Moreover, so far, it has been put in place by exactly threecompanies (Par Pharmaceuticals, Aflac and Verizon). [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]
26 Feb 2008, 8:00 am
Another firm that saw majority support for a "say on pay" proposal in 2007, Par Pharmaceuticals, has agreed to adopt the yearly advisory votes. [read post]
12 Feb 2008, 11:34 am
Verizon, Par Pharmaceutical and Aflac became the first US companies over the last year to adopt policies requiring an advisory vote of shareholders on company executive compensation practices. [read post]
30 Jan 2008, 7:52 am
Three companies--Par Pharmaceuticals, Verizon Communications, and Aflacâ€â [read post]
17 Jan 2008, 7:55 am
The other day we got a tip that the FDA had just posted something on its website that we'd want to read. [read post]
4 Dec 2007, 6:33 pm
Pharmaceutical Resources and Par Pharmaceuticals v. [read post]